Advertisement
Singapore markets close in 6 hours 15 minutes

  • Straits Times Index

    3,293.42
    +20.70 (+0.63%)
     

  • Nikkei

    38,336.24
    +784.08 (+2.09%)
     

  • Hang Seng

    17,097.76
    +268.83 (+1.60%)
     

  • FTSE 100

    8,044.81
    +20.94 (+0.26%)
     

  • Bitcoin USD

    66,629.84
    -210.48 (-0.31%)
     

  • CMC Crypto 200

    1,433.55
    +18.79 (+1.33%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • Dow

    38,503.69
    +263.71 (+0.69%)
     

  • Nasdaq

    15,696.64
    +245.33 (+1.59%)
     

  • Gold

    2,332.30
    -9.80 (-0.42%)
     

  • Crude Oil

    83.31
    -0.05 (-0.06%)
     

  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     

  • FTSE Bursa Malaysia

    1,567.15
    +5.51 (+0.35%)
     

  • Jakarta Composite Index

    7,165.20
    +54.39 (+0.76%)
     

  • PSE Index

    6,571.37
    +64.57 (+0.99%)
     

Opiant Pharmaceuticals to Report Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 11, 2021

Opiant Pharmaceuticals, Inc.
·1-min read

SANTA MONICA, Calif., Oct. 21, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report third quarter 2021 financial results and pipeline updates on Thursday, November 11, 2021, after U.S. financial markets close.

The Company’s management team is scheduled to host a conference call and webcast at 4:30 p.m. ET on Thursday, November 11, 2021 to discuss the results and operational progress.

To access the call, please dial 877-407-0792 in the U.S. or 201-689-8263 outside the U.S. and provide the conference ID number: 13723604. To access the live webcast, please visit http://public.viavid.com/index.php?id=146696. Following the live webcast, an archived version of the call will be available on the website.

Thursday November 11 @ 4:30 pm ET

Domestic:

877-407-0792

International:

201-689-8263

Conference ID:

13723604

Webcast:

http://public.viavid.com/index.php?id=146696

About Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: www.opiant.com and follow Opiant on Twitter (@Opiant_Pharma).

For Media and Investor Inquiries:
Ben Atkins, Opiant
(310) 598-5410
batkins@opiant.com